Buscar

Estamos realizando la búsqueda. Por favor, espere...

Detalle_Publicacion

Incidence, associated factors and clinical impact of severe infections in a large, multicentric cohort of patients with systemic lupus erythematosus

Abstract: OBJECTIVES: To estimate the incidence of severe infection and investigate the associated factors and clinical impact in a large systemic lupus erythematosus (SLE) retrospective cohort. METHODS: All patients in the Spanish Rheumatology Society Lupus Registry (RELESSER) who meet ?4 ACR-97 SLE criteria were retrospectively investigated for severe infections. Patients with and without infections were compared in terms of SLE severity, damage, comorbidities, and demographic characteristics. A multivariable Cox regression model was built to calculate hazard ratios (HRs) for the first infection. RESULTS: A total of 3658 SLE patients were included: 90% female, median age 32.9 years (DQ 9.7), and mean follow-up (months) 120.2 (±87.6). A total of 705 (19.3%) patients suffered ?1 severe infection. Total severe infections recorded in these patients numbered 1227. The incidence rate was 29.2 (95% CI: 27.6-30.9) infections per 1000 patient years. Time from first infection to second infection was significantly shorter than time from diagnosis to first infection (p < 0.000). Although respiratory infections were the most common (35.5%), bloodstream infections were the most frequent cause of mortality by infection (42.0%). In the Cox regression analysis, the following were all associated with infection: age at diagnosis (HR = 1.016, 95% CI: 1.009-1.023), Latin-American (Amerindian-Mestizo) ethnicity (HR = 2.151, 95% CI: 1.539-3.005), corticosteroids (?10mg/day) (HR = 1.271, 95% CI: 1.034-1.561), immunosuppressors (HR = 1.348, 95% CI: 1.079-1.684), hospitalization by SLE (HR = 2.567, 95% CI: 1.905-3.459), Katz severity index (HR = 1.160, 95% CI: 1.105-1.217), SLICC/ACR damage index (HR = 1.069, 95% CI: 1.031-1.108), and smoking (HR = 1.332, 95% CI: 1.121-1.583). Duration of antimalarial use (months) proved protective (HR = 0.998, 95% CI: 0.997-0.999). CONCLUSIONS: Severe infection constitutes a predictor of poor prognosis in SLE patients, is more common in Latin-Americans and is associated with age, previous infection, and smoking. Antimalarials exerted a protective effect.

Otras publicaciones de la misma revista o congreso con autores/as de la Universidad de Cantabria

 Fuente: Semin Arthritis Rheum. 2017 Aug;47(1):38-45

Editorial: Elsevier

 Fecha de publicación: 01/08/2017

Nº de páginas: 8

Tipo de publicación: Artículo de Revista

 DOI: 10.1016/j.semarthrit.2017.01.010

ISSN: 0049-0172,1532-866X

Autoría

RÚA FIGUEROA, ÍÑIGO

LÓPEZ LONGO, FRANCISCO JAVIER

GALINDO IZQUIERDO, MARÍA

JAIME CALVO ALEN

CAMPO, VÍCTOR DEL

OLIVÉ MARQUÉS, ALEJANDRO

PÉREZ VICENTE, SABINA

FERNÁNDEZ NEBRO, ANTONIO

ANDRÉS, MARIANO

ERAUSQUIN, CELIA

TOMERO, EVA

HORCADA, LORETO

URIARTE, ESTHER

FREIRE, MERCEDES

MONTILLA, CARLOS

SÁNCHEZ ATRIO, ANA

SANTOS, G.

BOTEANU, ALINA L.

DÍEZ ÁLVAREZ, ELVIRA